-
公开(公告)号:US20240294637A1
公开(公告)日:2024-09-05
申请号:US18652625
申请日:2024-05-01
CPC分类号: C07K16/2803 , A61P35/02 , C07K2317/24 , C07K2317/32 , C07K2317/77 , C07K2317/92
摘要: The present invention relates to an isolated antibody, or antigen binding fragment thereof, which specifically binds to an extracellular domain of CD300f, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain variable region which comprises: (a) an amino acid sequence that is at least 70% identical to the amino acid sequence represented by SEQ ID NO: 1; and/or (b) a complementarity determining region 1 (CDR1) that comprises the amino acid sequence represented by SEQ ID NO: 2, a complementarity determining region 2 (CDR2) that comprises an amino acid sequence that is represented by SEQ ID NO: 3, and/or a complementarity determining region 3 (CDR3) that comprises an amino acid sequence that is represented by SEQ ID NO: 4, compositions comprising the antibody, antigen binding fragment thereof, and uses for therapy.
-
公开(公告)号:US20230031629A1
公开(公告)日:2023-02-02
申请号:US17782263
申请日:2020-12-04
IPC分类号: C07K16/28 , A61K35/17 , A61K35/15 , A61K39/00 , A61K39/385 , A61P31/12 , A61P35/00 , A61P37/04 , A61K39/12 , A61K47/68
摘要: The disclosure relates to a method of antigen loading an antigen presenting cell or precursor thereof with a target antigen for presentation of the target antigen to a T cell, comprising contacting the antigen presenting cell or precursor thereof with a CD300f binding protein in the presence of the target antigen The disclosure also relates to compositions for antigen loading antigen presenting cells or precursors thereof, to immunoconjugates for antigen loading antigen presenting cells or precursors thereof, and use of antigen-loaded antigen presenting cells and immunoconjugates for promoting or increasing a T cell response to a target antigen in a subject.
-
公开(公告)号:US09840559B2
公开(公告)日:2017-12-12
申请号:US14765236
申请日:2014-01-31
申请人: DENDROCYTE BIOTECH PTY LTD , THE UNIVERSITY OF QUEENSLAND , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人: Therese Ann Seldon , David John Munster , Derek Nigel John Hart , Martina Louise Jones , Trent Phillip Munro , Stephen Michael Mahler , Eunice Yu Zhou , James D. Marks
CPC分类号: C07K16/2803 , A61K2039/505 , A61K2039/545 , C07K2317/21 , C07K2317/32 , C07K2317/34 , C07K2317/41 , C07K2317/55 , C07K2317/56 , C07K2317/622 , C07K2317/626 , C07K2317/72 , C07K2317/732 , C07K2317/92
摘要: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis, or prognosis.
-
公开(公告)号:US11987625B2
公开(公告)日:2024-05-21
申请号:US16462688
申请日:2017-11-22
CPC分类号: C07K16/2803 , A61P35/02 , C07K2317/24 , C07K2317/32 , C07K2317/77 , C07K2317/92
摘要: The present disclosure relates to an isolated antibody, or antigen binding fragment thereof, which specifically binds to an extracellular domain of cd300f, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain variable region which comprises: (a) an amino acid sequence that is at least 70% identical to the amino acid sequence represented by seq id no: 1; and/or (b) a complementarity determining region 1 (cdr1) that comprises the amino acid sequence represented by seq id no: 2, a complementarity determining region 2 (cdr2) that comprises an amino acid sequence that is represented by seq id no: 3, and/or a complementarity determining region 3 (cdr3) that comprises an amino acid sequence that is represented by seq id no: 4, compositions comprising the antibody, antigen binding fragment thereof, and uses for therapy.
-
公开(公告)号:US20180201681A1
公开(公告)日:2018-07-19
申请号:US15808423
申请日:2017-11-09
申请人: DENDROCYTE BIOTECH PTY LTD , THE UNIVERSITY OF QUEENSLAND , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人: Therese Ann Seldon , David John Munster , Derek Nigel John Hart , Martina Louise Jones , Trent Phillip Munro , Stephen Michael Mahler , Yu Zhou , James D. Marks
摘要: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis or prognosis.
-
公开(公告)号:US20170335006A1
公开(公告)日:2017-11-23
申请号:US15521124
申请日:2015-10-23
发明人: Joanne L CASEY , Andrew M COLEY
IPC分类号: C07K16/28 , A61K39/395
CPC分类号: C07K16/2896 , A61K39/395 , C07K16/2803 , C07K2317/21 , C07K2317/515 , C07K2317/55 , C07K2317/56 , C07K2317/92
摘要: An isolated or recombinant CD83 binding protein may include an antigen binding domain, wherein the antigen binding domain binds specifically to CD83 or a cell expressing CD83.
-
公开(公告)号:US20230063312A1
公开(公告)日:2023-03-02
申请号:US16462688
申请日:2017-11-22
摘要: The present disclosure relates to an isolated antibody, or antigen binding fragment thereof, which specifically binds to an extracellular domain of cd300f, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain variable region which comprises: (a) an amino acid sequence that is at least 70% identical to the amino acid sequence represented by seq id no: 1; and/or (b) a complementarity determining region 1 (cdr1) that comprises the amino acid sequence represented by seq id no: 2, a complementarity determining region 2 (cdr2) that comprises an amino acid sequence that is represented by seq id no: 3, and/or a complementarity determining region 3 (cdr3) that comprises an amino acid sequence that is represented by seq id no: 4, compositions comprising the antibody, antigen binding fragment thereof, and uses for therapy.
-
公开(公告)号:US20220296727A1
公开(公告)日:2022-09-22
申请号:US17631259
申请日:2020-07-30
发明人: Georgina Jane CLARK , Edward ABADIR
IPC分类号: A61K47/68 , A61K31/5517 , A61K31/7076 , C07K16/28 , A61P43/00
摘要: The present disclosure relates to an immunoconjugate including an antibody, or antigen binding fragment thereof, that specifically binds to CD300f, linked to at least one cytotoxic agent, and to compositions including the immunoconjugate, and use of the immunoconjugate for depleting haematopoietic stem and progenitor cells, for preparing a subject haematopoietic stem cell transplantation, and for the treatment of CD300f associated conditions.
-
公开(公告)号:US20200339684A1
公开(公告)日:2020-10-29
申请号:US16924860
申请日:2020-07-09
申请人: DENDROCYTE BIOTECH PTY LTD , THE UNIVERSITY OF QUEENSLAND , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人: Therese Ann Seldon , David John Munster , Derek Nigel John Hart , Martina Louise Jones , Trent Phillip Munro , Stephen Michael Mahler , Yu Zhou , James D. Marks
IPC分类号: C07K16/28
摘要: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis, or prognosis.
-
公开(公告)号:US10781255B2
公开(公告)日:2020-09-22
申请号:US15808423
申请日:2017-11-09
申请人: DENDROCYTE BIOTECH PTY LTD , THE UNIVERSITY OF QUEENSLAND , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人: Therese Ann Seldon , David John Munster , Derek Nigel John Hart , Martina Louise Jones , Trent Phillip Munro , Stephen Michael Mahler , Yu Zhou , James D. Marks
摘要: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis or prognosis.
-
-
-
-
-
-
-
-
-